WeVote
Log In

Bill

GE

Bill

HR 8005

Stop Pills That Kill Act

119th Congress Introduced by Gabe Evans

Introduced bill addressing pharmaceutical safety concerns; referred to Judiciary and Energy/Commerce committees for consideration of drug regulation provisions.

Introduced in House
0
WeVote Research Nonpartisan
Bill Summary · HR 8005

Legislative bill overview

HR 8005, the "Stop Pills That Kill Act," was introduced in March 2026 and referred to both the Judiciary and Energy and Commerce committees. The bill's specific provisions are not detailed in the available information, but the title suggests it addresses pharmaceutical safety concerns related to medications with serious adverse effects or misuse potential.

Why is this important

Pharmaceutical safety legislation affects millions of Americans who rely on medications and shapes how the FDA regulates drug approval and distribution. The bill's focus on "pills that kill" indicates concern about either prescription drug overdose deaths, medication safety incidents, or potentially controlled substances—all significant public health issues.

Potential points of contention

  • Definition and scope: The bill's language regarding which medications qualify as dangerous could either be overly broad (restricting access to legitimate medications) or too narrow (failing to address actual harms)
  • FDA authority and existing processes: Questions about whether new regulatory mechanisms are needed or if current FDA oversight is adequate to address the bill's concerns
  • Access vs. safety trade-off: Balancing restrictions on dangerous medications against patients' needs for legitimate pharmaceutical treatment, particularly for chronic pain, mental health, or other serious conditions

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.